1 completed, 1 terminated, 1 unknown. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
Follow KM-819: new trials by email Literature Review of KM-819 trials Research Report on KM-819
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial to Evaluate the Efficacy and Safety of KM-819 Treatment to Slow the Progression of Multiple System Atrophy (MSA) KM-819, Placebo - Multiple System Atrophy | Phase 2 | Terminated | Kainos Medicine Inc. | 68 | 2023-02-27 | 2024-09-19 |
| A Study to Evaluate Safety and Efficacy of KM-819 in Healthy Adults and Participants with Parkinson's Disease KM-819, Placebo - Parkinson Disease | Phase 2 | Unknown | FAScinate Therapeutics Inc. | 314 | 2022-07-19 | 2025-03-05 |
| Phase I, KM-819 in Healthy Subjects for Parkinson's Disease KM-819, Placebo - Parkinson's Disease | Phase 1 | Completed | Kainos Medicine Inc. | 88 | 2016-11-01 | 2020-04-13 |
Parkinson Disease (2) · Autoimmune Lymphoproliferative Syndrome, Type IA (1) · Multiple System Atrophy (1) · Neurodegenerative Diseases (1) · Primary Dysautonomias (1)
Kainos Medicine Inc. (2) · FAScinate Therapeutics Inc. (1)
South Korea (2) · United States (1)
Chong Sik Lee (1) · Jae Moon Lee, PhD (1)